PATENT CLAIM ANALYSIS

Application Number: 16047544
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["544", "280000"]

Abstract:
The present invention provides cyclobutyl substituted pyrrolopyrimidines and pyrrolopyridines of Formula I: wherein X, Y, Z, L, A, R 5 , n and m are defined above, as well as their compositions and methods of use, that modulate the activity of Janus kinases (JAKs) and are useful in the treatment of diseases related to the activity of JAKs including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.

Claim (Index 8):
The compound of  claim 7 , or a pharmaceutically acceptable salt thereof, wherein R 6  is H, R 7  is H or methyl, and R 7a  is CN.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.49123
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13300094', '13300137', '12872925', '13896802', '13588776']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7877472715719915
- 35 USC 102 Novelty (BERT): 0.6463018858612212
- Combined Prediction Score: 0.7736027330009145
- Mean Citation Score: 523.41831
- Max Citation Score: 591.9107
- Similarity Product: 526.8187193361879

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test